Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
06/10/2010 | WO2010065834A1 Compositions and methods for selective inhibition of pro-angiogenic vegf isoforms |
06/10/2010 | WO2010065830A1 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same |
06/10/2010 | WO2010065792A2 Treatment of erythropoietin (epo) related diseases by inhibition of natural antisense transcript to epo |
06/10/2010 | WO2010065787A2 Treatment of tumor suppressor gene related diseases by inhibition of natural antisense transcript to the gene |
06/10/2010 | WO2010065782A1 Method for treating pulmonary diseases using rho kinase inhibitor compounds |
06/10/2010 | WO2010065756A2 Usirna complexes |
06/10/2010 | WO2010065735A2 Methods and compositions for treating p.acnes |
06/10/2010 | WO2010065725A2 Regulation of cotton fiber growth by extracellular nucleotides and ectoapyrases |
06/10/2010 | WO2010065671A2 Treatment of vascular endothelial growth factor (vegf) related diseases by inhibition of natural antisense transcript to vegf |
06/10/2010 | WO2010065662A2 Treatment of sirtuin 1 (sirt1) related diseases by inhibition of natural antisense transcript to sirtuin 1 |
06/10/2010 | WO2010065630A2 Compositions and methods for treating hepatic neoplasia |
06/10/2010 | WO2010065629A2 Nucleic acid amplification |
06/10/2010 | WO2010065594A2 Cells for increased protein expression comprising one or more release factors and methods of use |
06/10/2010 | WO2010065578A2 POLYPEPTIDES COMPRISING Fc FRAGMENTS OF IMMUNOGLOBULIN G (IgG) AND METHODS OF USING THE SAME |
06/10/2010 | WO2010065576A2 The antisense transcriptomes of cells |
06/10/2010 | WO2010065557A2 Methods of determining efficacy of glucocorticoid treatment of eosinophilic esophagitis |
06/10/2010 | WO2010065534A2 Miscanthus transformation methods |
06/10/2010 | WO2010065479A2 Compositions and methods using alpha beta-crystallin in protecting the myocardium from ischemia/reperfusion injury |
06/10/2010 | WO2010065470A2 Compositions and methods for detecting background male dna during fetal sex determination |
06/10/2010 | WO2010065439A1 Variants of fibroblast growth factor 21 |
06/10/2010 | WO2010065437A1 Modulation of olfml-3 mediated angiogenesis |
06/10/2010 | WO2010065420A2 Universal biological sample processing |
06/10/2010 | WO2010065414A1 Use of micrornas to control virus helper nucleic acids |
06/10/2010 | WO2010065407A2 High affinity recombinant sea lamprey antibodies selected by a yeast surface display platform |
06/10/2010 | WO2010065123A1 Genome editing in rats using zinc-finger nucleases |
06/10/2010 | WO2010065079A2 Antibodies to il-6 and use thereof |
06/10/2010 | WO2010065077A2 Antagonists of il-6 to prevent or treat thrombosis |
06/10/2010 | WO2010064934A1 Methods and compositions for the improvement of plant tolerance to environmental stresses |
06/10/2010 | WO2010064897A1 Farmesene synthase |
06/10/2010 | WO2010064893A1 Method for the reduction of repetitive sequences in adapter-ligated restriction fragments |
06/10/2010 | WO2010064861A2 Promoter variant and method for protein production using same |
06/10/2010 | WO2010064851A2 Mtor-targeted sirna having an interspecific cross reaction, recombination vector containing same, and pharmaceutical composition containing same |
06/10/2010 | WO2010064838A2 Cell permeable p53 recombinant protein, polynucleotide encoding the same, and anti-cancer composition containing the same as active ingredient |
06/10/2010 | WO2010064748A1 Screening of abundantly secreted proteins and their use as fusion partners for the production of recombinant proteins |
06/10/2010 | WO2010064747A1 Kit for diagnosing and screening liver cancer comprising antibodies specific to protein markers derived from hbx transgenic mouse and method for diagnosing and screening liver cancer using it |
06/10/2010 | WO2010064744A1 Mutant blocked in glycerol oxidaion pathway for producing 1,3-propanediol |
06/10/2010 | WO2010064738A1 Plant producing sirna of animal virus and uses thereof |
06/10/2010 | WO2010064736A1 Therapeutic agent for cancer |
06/10/2010 | WO2010064702A1 Biomarker for predicting prognosis of cancer |
06/10/2010 | WO2010064697A1 Anti-nr10 antibody, and use thereof |
06/10/2010 | WO2010064634A1 Method for preparing fecal sample, solution for preparing fecal sample, and feces collection kit |
06/10/2010 | WO2010064628A1 Method for preparing sample containing nucleic acid, solution for preparing sample, and method for analyzing nucleic acid |
06/10/2010 | WO2010064598A1 Mutant gluconate dehydrogenase |
06/10/2010 | WO2010064456A1 Anti-nr10 antibodies and utilization of the same |
06/10/2010 | WO2010064454A1 Method for producing antibody directed against protein expressed on cell surface |
06/10/2010 | WO2010064430A1 Wdrpuh epitope peptides and vaccines containing the same |
06/10/2010 | WO2010064425A1 Method for inhibiting proliferation of cells |
06/10/2010 | WO2010064373A1 Il-8 inhibitor and process for producing same |
06/10/2010 | WO2010064231A1 Methods of analyzing a-i rna editing and nucleic acid constructs capable of same |
06/10/2010 | WO2010064207A2 Selective anticancer chimeric peptide |
06/10/2010 | WO2010064164A1 Bovine viral diarrhea virus with a modified erns protein |
06/10/2010 | WO2010063837A1 Parallel extraction of different biomolecules from formalin-fixed tissue |
06/10/2010 | WO2010063833A2 Plant growth promoting protein complex |
06/10/2010 | WO2010063804A1 Novel method for generation of rna virus |
06/10/2010 | WO2010063783A2 Modulating XRN2 |
06/10/2010 | WO2010063766A1 Bioprocessing ligno-cellulose into ethanol with recombinant clostridium |
06/10/2010 | WO2010063711A1 Method for introducing diversity into and assembly of polynucleotide sequences |
06/10/2010 | WO2010063637A1 Plants having enhanced abiotic stress tolerance and/or enhanced yield-related traits and a method for making the same |
06/10/2010 | WO2010063460A1 Recombinant production of hydrophobic peptides and fusion proteins for use in producing same |
06/10/2010 | WO2010063300A1 Isogenic human cell lines comprising mutated cancer alleles and process using the cell lines |
06/10/2010 | WO2010063288A2 Barley and malt-derived beverages with low dms level |
06/10/2010 | WO2010063250A1 Antimicrobial peptides made of hydra |
06/10/2010 | WO2010063172A1 An elp fusion protein and uses thereof |
06/10/2010 | WO2010063162A1 Drought induced rice flower specific promoter and use thereof |
06/10/2010 | WO2010063124A1 Peptide therapeutic conjugates and uses thereof |
06/10/2010 | WO2010063123A1 Leptin and leptin analog conjugates and uses thereof |
06/10/2010 | WO2010063122A1 Conjugates of neurotensin or neurotensin analogs and uses thereof |
06/10/2010 | WO2010063113A1 Anti-cobra toxin antibody fragments and method of producing a vhh library |
06/10/2010 | WO2010045211A3 Genetic loci associated with northern leaf blight resistance in maize |
06/10/2010 | WO2010038083A3 Transcription factor decoys |
06/10/2010 | WO2010036978A3 Novel vectors for production of growth hormone |
06/10/2010 | WO2010036976A3 Novel vectors for production of antibodies |
06/10/2010 | WO2010036860A3 Compatible display vector systems |
06/10/2010 | WO2010036408A3 Lysk endolysin is synergistic with lysostaphin against mrsa |
06/10/2010 | WO2010031772A3 Alternative butanol production process in a microbial cell |
06/10/2010 | WO2010031767A3 Fluorescent-labelled atpases |
06/10/2010 | WO2010030963A9 Modulation of bcl11a for treatment of hemoglobinopathies |
06/10/2010 | WO2010029378A3 Anti-protozoa compounds |
06/10/2010 | WO2010022395A3 Methods of reprogramming cells |
06/10/2010 | WO2010021961A3 Improved production of proteins with downstream box fusions in plastids and in bacteria |
06/10/2010 | WO2010020868A3 Increasing cell wall deposition and biomass in plants |
06/10/2010 | WO2010020777A3 Protein expression |
06/10/2010 | WO2010017551A3 Method for mir-125a in promoting hematopoietic stem cell self renewal and expansion |
06/10/2010 | WO2010013012A4 Hypothermia inducing polypeptides and uses thereof |
06/10/2010 | WO2010011680A3 Discovery and utilization of sorghum genes (ma5/ma6) |
06/10/2010 | WO2010008564A3 Plaice dna transposon system |
06/10/2010 | WO2009154790A3 Novel metastasis suppressor genes and uses thereof |
06/10/2010 | WO2009151584A3 Identification of contaminating bacteria in industrial ethanol fermentations |
06/10/2010 | WO2009149956A3 Fusion protein and use thereof |
06/10/2010 | WO2009143455A3 Engineering resistance to aliphatic alcohols |
06/10/2010 | WO2009127443A3 Transcription factors involved in salt stress in plants |
06/10/2010 | WO2004044123A9 Bioinformatically detectable group of novel regulatory genes and uses thereof |
06/10/2010 | US20100146672 Compositions and methods for increasing cellulose production |
06/10/2010 | US20100146671 Targeting vector |
06/10/2010 | US20100146670 Methods and compositions for altering plant biomass |
06/10/2010 | US20100146669 Wall-associated kinase-like polypeptide mediates nutritional status perception and response |
06/10/2010 | US20100146668 Insect-resistant protein and insect-resistance gene encoding the insect-resistant protein |
06/10/2010 | US20100146667 Transgenic plants expressing L3 delta proteins are resistant to trichothecene fungal toxins |
06/10/2010 | US20100146666 Method for producing plant with modified flower morphology |
06/10/2010 | US20100146665 Increased Stress Tolerance and Enhanced Yield in Plants |